Evidence map›Paper›PMID 32604765›Full record

ArticleViruses2020

Localization of Tobacco Yellow Dwarf Virus Replication Using the In Plant Activation (INPACT) Expression Platform.

Maiko Kato, Robert Harding, James Dale, Benjamin Dugdale

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Exploring the source of TYLCV resistance inFrontiers in plant science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maiko KatoCentre for Agriculture and the Bioeconomy, Queensland University of Technology, Brisbane, Queensland 4000, Australia.
Robert HardingCentre for Agriculture and the Bioeconomy, Queensland University of Technology, Brisbane, Queensland 4000, Australia.ORCID 0000-0002-9600-7287
James DaleCentre for Agriculture and the Bioeconomy, Queensland University of Technology, Brisbane, Queensland 4000, Australia.
Benjamin DugdaleCentre for Agriculture and the Bioeconomy, Queensland University of Technology, Brisbane, Queensland 4000, Australia.ORCID 0000-0003-2281-4809
Queensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Geminiviruses and their diseases are a considerable economic threat to a vast number of crops worldwide. Investigating how and where these viruses replicate and accumulate in their hosts may lead to novel molecular resistance strategies. In this study, we used the Rep-inducible In Plant Activation (INPACT) expression platform, based on the genome of tobacco yellow dwarf virus (TYDV), to determine where this model mastrevirus replicates in its host tobacco. By developing an infectious clone of TYDV and optimizing its delivery by agroinfiltration, we first established an efficient artificial infection process. When delivered into transgenic tobacco plants containing a TYDV-based INPACT cassette encoding the β-glucuronidase (GUS) reporter, we showed the virus activates GUS expression. Histology revealed that reporter gene expression was limited to phloem-associated cell types suggesting TYDV replication has a restricted tissue tropism.

Indexed as

GeminiviridaeGene Expression Regulation, PlantGenome, ViralGlucuronidaseHost Microbial InteractionsNicotianaPlant DiseasesPlants, Genetically ModifiedViral TropismVirus ReplicationGlucuronidasegeminivirusIn Plant Activation (INPACT)phloemreplicationtobaccoβ-glucuronidase (GUS)

Identifiers

PMID32604765
PMCPMC7354463
OpenAlexW3037769276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.